Genetics of Quantitative Traits Associated with Glaucoma
Genetics of Quantitative Traits Associated with Glaucoma
批准号:
8500293
负责人:
JOHN H FINGERT
金额:
$58.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2014-06-30
关键词:
AffectAllelesAmericanBioinformaticsBiologicalBlindnessCentral ScotomasClinical ManagementClinical Trials DesignCohort StudiesCongenic StrainCorneaDNADNA SequenceDetectionDevelopmentDiagnosisDiseaseEarly DiagnosisEarly treatmentEventFunctional disorderFutureGenesGeneticGenetic RiskGenomeGlaucomaGoalsHealthHumanInbred MouseInbred StrainInbred Strains MiceInterventionLeadLocationMapsMeasuresMonitorOcular HypertensionOptic NerveOrthologous GenePathogenesisPathway interactionsPatientsPhenotypePhysiologic Intraocular PressurePreventionProcessProductivityQuality of lifeQuantitative GeneticsQuantitative Trait LociResearchRiskStagingSusceptibility GeneTestingThickVariantVisionVisualVisual Fieldsbasecohortdisabilitygene discoverygenetic risk factorgenome wide association studyhigh intraocular pressurehypertension treatmentimprovedinsightnext generationoutcome forecastpreventprogramsresearch studytraittreatment trial
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Glaucoma is a leading cause of blindness and visual disability that has a major impact on the quality of life and productivity of millions of Americans. Glaucoma is defined by quantitative traits including, optic nerve cupping, visual field loss, and central corneal thickness. Intraocular pressure is another crucial quantitative trait that is monitored in glaucoma patients. The cascade of events that lead to glaucoma is not well known, which has hindered efforts for early detection and treatment of this condition. One way to investigate the pathogenesis of glaucoma is to identify disease-causing genes. Glaucoma is a heterogeneous disease and is likely caused by the interactions of many genes. This complexity has challenged efforts to identify genes that cause glaucoma. As a result, there is a critical need for research that focuses on glaucoma phenotypes with reduced complexity to facilitate the discovery of disease-causing genes. Our long-term goal is to identify and define pathways that lead from DNA variations in the genome to the vision loss of glaucoma. As stages of glaucoma pathogenesis are discovered, new interventions to prevent vision loss will become possible. Several quantitative features of the glaucoma phenotype (cup-to-disc ratio, corneal thickness, and intraocular pressure) are each independently associated with glaucoma and highly heritable. We hypothesize that the same genes that determine the magnitudes of these features of glaucoma will also be important in the pathogenesis of glaucoma overall. Furthermore, a single feature of glaucoma has less complexity than the whole disease. This reduced complexity will facilitate discovery of genetic factors for components of the glaucoma phenotype. Genes that control quantitative traits of glaucoma will be identified with studies of human cohorts and inbred mice. The Ocular Hypertension Treatment Study (OHTS) is a large treatment trial designed to show the efficacy of treating patients with high intraocular pressure. We will identify genetic factors that control the magnitude of cup-to-disc ratio, intraocular pressure, and corneal thickness by conducting a genome-wide association study of the patients in this trial (Specific Aim 1). Quantitative traits are often determined by the actions of many genetic factors. Studies of inbred mice with fixed genetic backgrounds have the advantage of reducing the complexity of these traits. By crossing inbred strains, specific risk alleles that determine a quantitative trait may be more easily recognized against the uniform genetic background. Therefore, we will study the genetic basis of an important quantitative feature of glaucoma (central corneal thickness) with crosses of inbred mice (Specific Aim 2). We expect that our proposed studies will identify new risk alleles for quantitative features of glaucoma. The discovery of such risk alleles will have an important impact on the future clinical management of glaucoma by facilitating early diagnosis and enabling the development of new sight- saving treatments.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3109/02713683.2012.754047
发表时间:
2013-02
期刊:
Current eye research
影响因子:
2
作者:
[Seo S, Solivan-Timpe F, Roos BR, Robin AL, Stone EM, Kwon YH, Alward WL, Fingert JH]
通讯作者:
Fingert JH
Copy number variations of TBK1 in Australian patients with primary open-angle glaucoma.
澳大利亚原发性开角青光眼患者TBK1的拷贝数变化。
DOI:
10.1016/j.ajo.2014.09.044
发表时间:
2015-01
期刊:
AMERICAN JOURNAL OF OPHTHALMOLOGY
影响因子:
4.2
作者:
[Awadalla, Mona S., Fingert, John H., Roos, Benjamin E., Chen, Simon, Holmes, Richard, Graham, Stuart L., Chehade, Mark, Galanopolous, Anna, Ridge, Bronwyn, Souzeau, Emmanuelle, Zhou, Tiger, Siggs, Owen M., Hewitt, Alex W., Mackey, David A., Burdon, Kathryn P., Craig, Jamie E.]
通讯作者:
Craig, Jamie E.
DOI:
10.1093/hmg/dds288
发表时间:
2012-10
期刊:
Human molecular genetics
影响因子:
3.5
作者:
[J. Fingert;B. Roos;Frances Solivan-Timpe;Kathy Miller;T. Oetting;Kai Wang;Young H. Kwon;T. Scheetz;E. Stone;W. Alward]
通讯作者:
J. Fingert;B. Roos;Frances Solivan-Timpe;Kathy Miller;T. Oetting;Kai Wang;Young H. Kwon;T. Scheetz;E. Stone;W. Alward
DOI:
10.1111/j.1469-1809.2012.00718.x
发表时间:
2012-09
期刊:
Annals of human genetics
影响因子:
1.9
作者:
[Wang K, Fingert JH]
通讯作者:
Fingert JH
DOI:
10.1001/jamaophthalmol.2014.104
发表时间:
2014-05
期刊:
JAMA OPHTHALMOLOGY
影响因子:
8.1
作者:
[Ritch, Robert, Darbro, Ben, Menon, Geeta, Khanna, Cheryl L., Solivan-Timpe, Frances, Roos, Ben R., Sarfarzi, Mansoor, Kawase, Kazuhide, Yamamoto, Tetsuya, Robin, Alan L., Lotery, Andrew J., Fingert, John H.]
通讯作者:
Fingert, John H.
共 7 条
Genetic Factors for Glaucoma in the OHTS; Risk, Progression and Mechanism
-
批准号:10716352
-
项目类别:
-
资助金额:$41.44万
-
财政年份:2023
-
负责人:JOHN H FINGERT
-
依托单位:
TBK1-Related Glaucoma
-
批准号:9013186
-
项目类别:
-
资助金额:$22.71万
-
财政年份:2015
-
负责人:JOHN H FINGERT
-
依托单位:
TBK1-Related Glaucoma
-
批准号:9187020
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2015
-
负责人:JOHN H FINGERT
-
依托单位:
Matrix Metallopeptidase 19 (MMP19) and Optic Nerve Disease
-
批准号:8919368
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2014
-
负责人:JOHN H FINGERT
-
依托单位:
Molecular Genetics of Norma Tension Glaucoma
-
批准号:9242640
-
项目类别:
-
资助金额:$45.3万
-
财政年份:2014
-
负责人:JOHN H FINGERT
-
依托单位:
Matrix Metallopeptidase 19 (MMP19) and Optic Nerve Disease
-
批准号:8753686
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2014
-
负责人:JOHN H FINGERT
-
依托单位:
Molecular Genetics of Norma Tension Glaucoma
-
批准号:8652634
-
项目类别:
-
资助金额:$45.3万
-
财政年份:2014
-
负责人:JOHN H FINGERT
-
依托单位:
Genetics of Quantitative Traits Associated with Glaucoma
-
批准号:7881518
-
项目类别:
-
资助金额:$80.68万
-
财政年份:2009
-
负责人:JOHN H FINGERT
-
依托单位:
Genetics of Quantitative Traits Associated with Glaucoma
-
批准号:8288845
-
项目类别:
-
资助金额:$61.21万
-
财政年份:2009
-
负责人:JOHN H FINGERT
-
依托单位:
Genetics of Quantitative Traits Associated with Glaucoma
-
批准号:7659174
-
项目类别:
-
资助金额:$63.45万
-
财政年份:2009
-
负责人:JOHN H FINGERT
-
依托单位:
Genetics of Quantitative Traits Associated with Glaucoma
-
批准号:8097992
-
项目类别:
-
资助金额:$61.21万
-
财政年份:2009
-
负责人:JOHN H FINGERT
-
依托单位:
The Molecular Genetics of Pigmentary Glaucoma
-
批准号:7494467
-
项目类别:
-
资助金额:$16.79万
-
财政年份:2006
-
负责人:JOHN H FINGERT
-
依托单位:
The Molecular Genetics of Pigmentary Glaucoma
-
批准号:7137854
-
项目类别:
-
资助金额:$15.98万
-
财政年份:2006
-
负责人:JOHN H FINGERT
-
依托单位:
The Molecular Genetics of Pigmentary Glaucoma
-
批准号:7677340
-
项目类别:
-
资助金额:$14.53万
-
财政年份:2006
-
负责人:JOHN H FINGERT
-
依托单位:
The Molecular Genetics of Pigmentary Glaucoma
-
批准号:7925657
-
项目类别:
-
资助金额:$14.88万
-
财政年份:2006
-
负责人:JOHN H FINGERT
-
依托单位:
The Molecular Genetics of Pigmentary Glaucoma
-
批准号:7287746
-
项目类别:
-
资助金额:$16.38万
-
财政年份:2006
-
负责人:JOHN H FINGERT
-
依托单位:
海外基金